uploads/2017/05/Part-4-2-1.png

Analysts’ Latest Recommendations for Eastman Chemical

By

Updated

Analysts’ recommendations for Eastman Chemical

As of May 30, 2017, 17 brokerage firms have been actively tracking Eastman Chemical (EMN) stock. About 65% of the analysts recommended a “buy” for the stock, while 35% of the analysts recommended a “hold.” None of the analysts recommended a “sell.”

Analysts’ consensus indicates that Eastman Chemical’s 12-month target price is $88.47, which implies a return potential of 10.6% from its closing price of $79.96 on May 30, 2017.

Article continues below advertisement

Most recommendations are a “buy”

Most analysts recommended a “buy” on Eastman Chemical, primarily influenced by its better-than-expected 1Q17 earnings. Eastman Chemical provided guidance that its earnings per share will be higher at 8%–10% in 2017.

Below are some of the recommended target prices for Eastman Chemical from well-known brokerage firms:

  • Barclays (BCS) rated Eastman Chemical as “equal weight” and provided a target price of $90, which implies a 12-month potential return of 12.5% over its closing price of $79.96 on May 30, 2017.
  • Morgan Stanley (MS) provided Eastman Chemical with a target price of $83, which implies a 12-month potential return of 3.8% over its closing price of $79.96 on May 30, 2017.
  • Nomura (NOM) rated Eastman Chemical as a “buy” with a target price of $87, which implies a 12-month potential return of 8.8% over its closing price of $79.96 on May 30, 2017.
  • J.P. Morgan (JPM) announced Eastman Chemical’s target price at $86, which implies a 12-month potential return of 7.6% over its closing price of $79.96 on May 30, 2017.

Notably, investors can indirectly hold Eastman Chemical by investing in the iShares US Basic Materials ETF (IYM), which has 11.4% of its portfolio in the company as of May 30, 2017.

Advertisement

More From Market Realist